Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

BackgroundAlthough a recent study reported that fibrates are associated with a low risk of cardiovascular (CV) death and can postpone the need for long-term hemodialysis in patients with advanced chronic kidney disease (CKD), little is known regarding whether the CV protective effects of fibrates ex...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Wen-Yu Ho, Chieh-Li Yen, Cheng-Chia Lee, Yi-Ran Tu, Chao-Yu Chen, Ching-Chung Hsiao, Pao-Hsien Chu, Hsiang-Hao Hsu, Ya-Chun Tian, Chih-Hsiang Chang
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Frontiers Media S.A. 2022-11-01
Loạt:Frontiers in Cardiovascular Medicine
Những chủ đề:
fibrates
hypertriglyceridemia
end-stage renal disease
cardiovascular
mortality
Truy cập trực tuyến:https://www.frontiersin.org/articles/10.3389/fcvm.2022.907539/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.907539/full

Những quyển sách tương tự